An Integrated Approach to Inhalation Drug Development
Inhalation drug delivery has traditionally been associated with a familiar set of indications, particularly asthma and chronic obstructive pulmonary disease (COPD). While these conditions continue to represent a major part of the inhalation market, emerging applications are expanding the field. Researchers and developers are increasingly investigating inhalation delivery across a broader range of therapeutic categories and technologies, with particular focus on dry powder systems and other inhaled dosage forms.